SEPTInvestingStart Free

MEDS SCHEDULE 13G: SEC filing

Hyperscale Data, Inc.

Filed with the SEC on · accession 0001214659-26-013939

MEDS filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 10, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -9.0% by the first close after the filing.

Summary of the filing

Hyperscale Data, Inc. filed a Schedule 13G reporting beneficial ownership of 501,204 shares of DataMeds AI, Inc. common stock (9.99%) issuable upon conversion of a convertible promissory note held by its subsidiary Ault Lending, LLC.

For details, click here →

Key details

Shares of common stock issuable upon conversion of convertible promissory note$501K
Additional shares issuable upon conversion subject to 9.99% blocker$124K
Shares issuable upon exercise of warrants subject to 4.99% blocker$245K
Reporting person / parent companyHyperscale Data, Inc.
Wholly owned subsidiary holding the convertible noteAult Lending, LLC
Intermediate parent of ault lending, llcAult Capital Group, Inc.
Issuer of the securitiesDataMeds AI, Inc.
Executive chairman, hyperscale data, inc.Milton C. Ault, III

How MEDS stock reacted

Close before

$0.98

Nov 9, 2026

First close after

-8.96%

$0.90

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MEDS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MEDS?

Click here

Frequently asked questions

What did MEDS file with the SEC on Nov 10, 2026?

MEDS filed a SCHEDULE 13G (SEC filing). Hyperscale Data, Inc. filed a Schedule 13G reporting beneficial ownership of 501,204 shares of DataMeds AI, Inc. common stock (9.99%) issuable upon conversion of a convertible promissory note held by its subsidiary Ault Lending, LLC.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did MEDS stock react to this filing?

MEDS closed at $0.98 before the filing and $0.90 on Nov 10, 2026 (-8.96%).

Other MEDS SEC filings

Get alerts when MEDS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
MEDS overviewMEDS analysisMEDS newsLatest SEC filings